Treatment outlook for adults with hypertrophic cardiomyopathy move from grim to good

Implantable defibrillators, along with other modern treatments, have reduced mortality rates and are helping patients with hypertrophic cardiomyopathy live longer, a study confirms. This research 'changes our perceptions of HCM from a grim, unrelenting, and largely untreatable condition to a contemporary disease with effective treatment options and a low rate of death,' states the lead researcher.